J Li,
F Sun, K He, L Zhang,
J Meng, D Huang… - Current …, 2024 - ingentaconnect.com
Background: Chemically modified therapeutic mRNAs have gained momentum recently. In
addition to commonly used modifications (eg, pseudouridine), 5moU is considered a …